CEFTAROLINE FOSAMIL
Details
- Status
- Prescription
- First Approved
- 2021-09-21
- Routes
- INTRAVENOUS
- Dosage Forms
- POWDER
CEFTAROLINE FOSAMIL Approval History
What CEFTAROLINE FOSAMIL Treats
2 indicationsCEFTAROLINE FOSAMIL is approved for 2 conditions since its original approval in 2021. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Acute Bacterial Skin and Skin Structure Infections
- Community-Acquired Bacterial Pneumonia
Drugs Similar to CEFTAROLINE FOSAMIL
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CEFTAROLINE FOSAMIL FDA Label Details
ProIndications & Usage
Ceftaroline fosamil for injection is a cephalosporin antibacterial indicated in adult and pediatric patients for the treatment of the following infection caused by designated susceptible bacteria: Acute bacterial skin and skin structure infections (ABSSSI) in adult and pediatric patients (at least 34 weeks gestational age and 12 days postnatal age) Community-acquired bacterial pneumonia (CABP) in adult and pediatric patients 2 months of age and older To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftaroline fosamil for injection and other antibacterial ...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.